Curtis Harwig - Concepedia

Author

Curtis Harwig

University of British Columbia

Also Known As

C. W. HARWIG, Curtis Harwig, Curtis W Harwig, Curtis W. Harwig, Harwig, C., Harwig, Curtis W.

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia TRIUMF KU Leuven Rega Institute for Medical Research University of Ottawa

About

Curtis Harwig is an author at University of British Columbia specializing in pharmacology, medicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	7	7	367
2	Medicine	7	7	286
3	Natural Sciences	5	5	147
4	Biochemistry	4	4	231
5	Health Sciences	2	2	151

Curtis Harwig

Publications

Citations

H-Index

Page 1

	Year	Citations
Toward [<sup>18</sup>F]-Labeled Aryltrifluoroborate Radiotracers: In Vivo Positron Emission Tomography Imaging of Stable Aryltrifluoroborate Clearance in Mice Richard Ting, Curtis Harwig, Ulrich auf dem Keller, Journal of the American Chemical Society EngineeringBoronic EsterOncologic ImagingAryltrifluoroborate RadiotracersPositron Emission Tomography	2008	127
Discovery of Novel Small Molecule Orally Bioavailable C−X−C Chemokine Receptor 4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication Renato T. Skerlj, Gary Bridger, Al Kaller, Journal of Medicinal Chemistry	2010	115
Substituent Effects on Aryltrifluoroborate Solvolysis in Water: Implications for Suzuki−Miyaura Coupling and the Design of Stable <sup>18</sup>F-Labeled Aryltrifluoroborates for Use in PET Imaging Richard Ting, Curtis Harwig, Justin Lo, The Journal of Organic Chemistry	2008	108
Novel Matrix Metalloproteinase Inhibitor [18F]Marimastat-Aryltrifluoroborate as a Probe for <i>In vivo</i> Positron Emission Tomography Imaging in Cancer Ulrich auf dem Keller, Caroline L. Bellac, Ying Li, Cancer Research EngineeringOncologic ImagingTumor BiologyPositron Emission TomographyOncology	2010	81
Characterization of <scp>AQX</scp>‐1125, a small‐molecule <scp>SHIP1</scp> activator Grant R. Stenton, Lloyd Mackenzie, Patrick Tam, British Journal of Pharmacology	2012	63
Taxamycins: a new enediyne family constructed from versatile disilyl-substituted building blocks Yee Fung Lu, Curtis Harwig, Alex G. Fallis The Journal of Organic Chemistry Combinatorial ChemistryPharmaceutical ScienceBioorganic ChemistryAltmetric Attention ScoreOrganic Chemistry	1993	56
Characterization of <scp>AQX</scp>‐1125, a small‐molecule <scp>SHIP1</scp> activator Grant R. Stenton, Lloyd Mackenzie, Patrick Tam, British Journal of Pharmacology	2012	50
Towards kit-like 18F-labeling of marimastat, a noncovalent inhibitor drug for in vivo PET imaging cancer associated matrix metalloproteases Ying Li, Richard Ting, Curtis Harwig, MedChemComm EngineeringOncologic ImagingMatrix MetalloproteasesKit-like 18F-labelingTumor Biology	2011	47
Synthesis of SHIP1‐Activating Analogs of the Sponge Meroterpenoid Pelorol Labros G. Meimetis, Matt Nodwell, Lu Yang, European Journal of Organic Chemistry Medicinal ChemistryEnantioselective SynthesisEngineeringBiotechnologyAbstract Two	2012	41
A cofactor approach to copper-dependent catalytic antibodies Kenneth M. Nicholas, Paul Wentworth, Curtis Harwig, Proceedings of the National Academy of Sciences	2002	41

Page 1